Brooks Laboratories Ltd share price logo

Brooks Laboratories Share Price

NSE: BROOKS

BSE: 533543

Small Cap

Healthcare Sector

₹61.90

-2.50

(-3.88%)

as on

bell
The current prices are delayed by 15 mins, login to check live prices.

Tech Chart

Brooks Laboratories Stock Performance

as on January 29, 2026 at 4:02 pm IST

  • Day's Low

    Day's High

    ₹61.60
    ₹65.69
    downward going graph

    0.48%

    Downside

    6.12%

    Upside

    downward going graph

  • 52 Week's Low

    52 Week's High

    ₹61.60
    ₹173.65
    downward going graph

    0.48%

    Downside

    180.53%

    Upside

    downward going graph

Brooks Laboratories share price movements today

Previous Close
₹64.40
Open
₹65.00
Volume
57.86K
Upper Circuit
₹77.28
Lower Circuit
₹51.52
Day's Low - High
₹61.60 - ₹65.69
52 Week Low - High
₹61.60 - ₹173.65

Brooks Laboratories Historical Returns

1 Month Return
-17.19 %
3 Month Return
-39.24 %
1 Year Return
-56.44 %
3 Year Return
-36.05 %
5 Year Return
+ 2.71 %

Brooks Laboratories Fundamentals

as on January 29, 2026 at 4:02 pm IST

Market Cap

₹189.70 Cr

Return on Equity (ROE)

2.43

PE Ratio (TTM)

17.55

Return on capital employed (ROCE)

3.19

Industry PE ratio

39.98

Beta (LTM)

1.36

P/B Ratio

2.76

Dividend Yield

0

PEG Ratio

1.54

Quarterly Earnings Growth YOY

-301.52

EPS (TTM)

-3.38

Sector

Pharmaceuticals

Book Value

33.3

Technical Analysis

Bearish

View Technical Analysis

Brooks Laboratories Stock Valuation

as on January 29, 2026 at 4:02 pm IST

Brooks Laboratories in the last 5 years

  • Overview

  • Trends

Lowest (-293.64x)

July 22, 2025

Today (17.55x)

January 28, 2026

Industry (39.98x)

January 28, 2026

Highest (36.88x)

October 3, 2025

LowHigh

Today’s Price to Earnings Ratio: 17.55x

Brooks Laboratories Ltd vs Peer Comparison

Compare market cap, revenue, PE, and other key metrics of Brooks Laboratories with its industry peers.

Company
Analyst View
Market Cap(in ₹ Cr)
5 Year CAGRDebt to Asset Ratio
Net Profit(in ₹ Cr)
Yearly Revenue(in ₹ Cr)
Brooks Laboratories Ltd image
Brooks Laboratories Ltd
NA189.700.54%0.54-1082
Shree Ganesh Biotech India Ltd image
Shree Ganesh Biotech India Ltd
NA25.91-17.82%0.00222
Sanjivani Paranteral Ltd image
Sanjivani Paranteral Ltd
NA215.28320.95%0.61870
Fabino Enterprises Ltd image
Fabino Enterprises Ltd
NA3.07-12.76%0.65NA18
Shree Ganesh Remedies Ltd image
Shree Ganesh Remedies Ltd
NA516.3939.94%0.6123108
See all

Brooks Laboratories Share Price Target

Get share price movements and forecasts by analysts on Brooks Laboratories.

Source: S&P Global Market Intelligence

Brooks Laboratories Stock’s Investor Sentiment and Interest

Search interest for Brooks Laboratories Ltd Stock has increased by 168% in the last 30 days, reflecting an upward trend in search activity.

Time period: to

Change:168% versus previous 30 day period

Brooks Laboratories Ltd Quarterly Profit & Loss

Figures in Rupees Crores

Mar 2023
Jun 2023
Sep 2023
Dec 2023
Mar 2024
Jun 2024
Sep 2024
Dec 2024
Mar 2025
Jun 2025
Sep 2025
Sales
12.61
15.7
24.32
21.75
17.72
17.93
20.79
20.52
23.32
25.51
23.45
Other Income
0.03
0.05
0.09
0.16
0.65
0.07
0.2
0.03
0.62
7.15
6.13
Total Income
12.64
15.76
24.41
21.9
18.38
18
20.99
20.54
23.94
32.66
29.58
Expenses
16.31
19.62
25.42
25.11
27.25
19.85
24.2
22.01
24.57
22.39
20.93
Operating Profit
-3.7
-3.92
-1.1
-3.36
-9.53
-1.92
-3.41
-1.49
-1.25
3.12
2.52
Operating Profit Margin %
-29.34%
-24.97%
-4.52%
-15.45%
-53.78%
-10.71%
-16.4%
-7.26%
-5.36%
12.23%
10.75%
Profit Before Interest, Tax and Depreciation
-3.67
-3.86
-1.01
-3.21
-8.88
-1.85
-3.21
-1.46
-0.63
10.28
8.65
Interest
0.18
0.17
0.19
0.21
0.27
0.16
0.32
0.28
0.26
0.3
0.28
Depreciation
0.44
0.44
0.44
0.43
0.46
0.4
0.43
0.38
0.39
0.39
0.39
Profit Before Tax
-4.29
-4.47
-1.64
-3.85
-9.61
-2.41
-3.96
-2.12
-1.28
9.59
7.98
Tax Paid
-
-
-
0.03
-
-
-
-
0.18
-
-
Profit After Tax
-4.29
-4.47
-1.64
-3.88
-9.61
-2.41
-3.96
-2.13
-1.46
9.58
7.98
Total Net profit including share of profit / Loss from associate company
-4.29
-4.47
-1.64
-3.88
-9.61
-2.41
-3.96
-2.13
-1.46
9.58
7.98
EPS
-1.75
-1.81
-0.6
-1.51
-3.77
-0.94
-1.51
-1.75
-0.54
3.25
2.71
Actual EPS
-1.75
-1.81
-0.6
-1.51
-3.77
-0.94
-1.51
-1.75
-0.54
3.25
2.71
Adjusted EPS
-1.73
-1.79
-0.6
-1.51
-3.77
-0.94
-1.51
-1.75
-0.54
3.25
2.71
Diluted EPS
-1.75
-1.81
-0.6
-1.51
-3.77
-0.94
-1.51
-1.75
-0.54
3.25
2.71

Brooks Laboratories Ltd Annual Profit & Loss

Figures in Rupees Crores

Mar 2021
Mar 2022
Mar 2023
Mar 2024
Mar 2025
Sales
77.25
91.08
63.2
79.49
82.56
Other Income
0.74
0.91
0.57
0.92
0.88
Total Income
77.98
91.99
63.77
80.4
83.44
Expenses
76.73
105.44
92.93
97.35
90.6
Operating Profit
0.52
-14.36
-29.73
-17.86
-8.04
Operating Profit Margin %
0.67%
-15.77%
-47.04%
-22.47%
-9.74%
Profit Before Interest, Tax and Depreciation
1.25
-13.45
-29.16
-16.95
-7.16
Interest
3.1
3.1
2.18
0.84
1.03
Depreciation
7.14
7.35
7.03
1.77
1.6
Profit Before Tax
-8.99
-23.9
-38.37
-19.56
-9.79
Tax Paid
10.38
-4.59
-7.32
0.03
0.18
Profit After Tax
-19.38
-19.31
-31.05
-19.59
-9.97
Total Net profit including share of profit / Loss from associate company
-19.38
-19.31
-31.05
-19.59
-9.97
EPS
-6.31
-7.82
-12.57
-7.67
-3.72
Actual EPS
-6.31
-7.82
-12.57
-7.67
-3.72
Adjusted EPS
-6.25
-7.74
-12.45
-7.67
-3.72
Diluted EPS
-6.31
-7.82
-12.57
-7.67
-3.72

Brooks Laboratories Ltd Cash Flow

Figures in Rupees Crores

Mar 2021
Mar 2022
Mar 2023
Mar 2024
Mar 2025
Net Cash from Operating Activities
4.46
-37.44
-14.49
-9.8
2.63
Cash Flow from Investing Activities
-5.13
-20.52
0.49
0.18
-45.14
Cash Flow from Financing Activities
1.15
64.07
11.41
9.72
42.42
Net Cash Flow
0.49
1.72
-2.58
0.1
-0.08

Brooks Laboratories Stock Shareholding Pattern

Numbers in percentages

Mar 2023
Jun 2023
Aug 2023
Sep 2023
Dec 2023
Mar 2024
Jun 2024
Sep 2024
Dec 2024
Jan 2025
Mar 2025
Jun 2025
Sep 2025
Dec 2025
Promoters
66.41%
66.41%
63.59%
63.59%
63.59%
63.59%
63.59%
63.59%
59.06%
52.62%
52.62%
52.62%
52.62%
52.62%
DII
0.06%
0%
1.25%
2.46%
3.86%
3.86%
3.86%
3.86%
3.86%
9.9%
10.38%
10.38%
10.38%
10.38%
FII
0%
0%
0%
0%
0%
0%
0%
0.02%
0.01%
0%
0.05%
0%
0.01%
0.09%
Public
33.52%
33.59%
35.16%
33.94%
32.55%
32.55%
32.55%
32.53%
37.08%
37.48%
36.95%
37%
37%
36.91%
Total Outstanding Shares
2,47,02,812
2,47,02,812
2,62,46,738
2,62,46,738
2,62,46,738
2,62,46,738
2,62,46,738
2,62,46,738
2,62,46,738
2,94,57,248
2,94,57,248
2,94,57,248
2,94,57,248
2,94,57,248
Total Shareholders
10,709
11,216
11,141
10,686
10,028
11,432
11,543
11,282
10,521
10,374
10,537
10,317
10,078
10,532

Mutual Funds that own Brooks Laboratories Stock

Check out the Mutual Funds with significant holdings in Brooks Laboratories.

Funds
Holdings
Shares Held
Quant Business Cycle Fund Direct Growth
Quant Business Cycle Fund Direct Growth
2.22%
2916111

Brooks Laboratories Corporate Actions

View detailed summary of the earnings and dividend history of Brooks Laboratories.

  • Brooks Laboratories Ltd Earnings Results

    Brooks Laboratories Ltd’s net profit jumped 301.52% since last year same period to ₹7.98Cr in the Q2 2025-2026. On a quarterly growth basis, Brooks Laboratories Ltd has generated -16.7% fall in its net profits since last 3-months.

    Read More about Earnings Results

Insights on Brooks Laboratories Ltd

Insights help you understand the recent movement of the company's critical parameters, giving you an overall view of the company.

  • imgPOSITIVE IMPACT

    FII Holding Up

    img

    Foreign Institutions have increased holdings from 0.01% to 0.09% in Dec 2025 quarter

  • imgNO EFFECT

    Against Peers

    img

    In the last 3 years, Torrent Pharmaceuticals Ltd has given 155.8% return, outperforming this stock by 191.8%

  • imgNO EFFECT

    Against Peers

    img

    In the last 1 year, Torrent Pharmaceuticals Ltd has given 17.8% return, outperforming this stock by 74.2%

  • imgNO EFFECT

    Promoter Holding Unchanged

    img

    Promoters holdings remained unchanged at 52.62% of holdings in Dec 2025 quarter

  • imgNEGATIVE IMPACT

    Retail Holding Down

    img

    Retail Investor have decreased holdings from 37.00% to 36.91% in Dec 2025 quarter

  • imgNEGATIVE IMPACT

    Price Dip

    img

    In the last 3 months, BROOKS stock has moved down by -39.2%

  • imgNEGATIVE IMPACT

    Profit Down

    img

    Netprofit is down for the last 2 quarters, 9.58 Cr → 7.98 Cr (in ₹), with an average decrease of 16.7% per quarter

  • imgNEGATIVE IMPACT

    Revenue Fall

    img

    Revenue is down for the last 2 quarters, 32.66 Cr → 29.58 Cr (in ₹), with an average decrease of 9.4% per quarter

About Brooks Laboratories Ltd

Brooks Laboratories Ltd is an esteemed pharmaceutical manufacturing company that has established plants in Baddi, Himachal Pradesh and Vadodara, Gujarat. The Vadodara facility was approved by the European Medicine Agency, and the company’s product portfolio consists of 28 injectables, 19 tablets and 2 dry syrups that are catered to the critical care segment. They are sourced from suppliers like Rajasthan Antibiotics Ltd, Aurobindo Pharma Ltd, DSM Anti Infectives Ltd and Qilu Pharmaceutical Company Ltd, and served to clients like Zydus Cadila, Aristo Pharmaceuticals Pvt Ltd, FDC Ltd, Nectar Lifesciences Ltd and Sanat Products Ltd.

Brooks Laboratories Ltd was established in January 2002 and it started operations and commercial production in May and June 2006 respectively. It obtained an ISO 9001:2008 Certificate in August 2007 and an Import License from Drugs Controller General of India in October 2006. On August 2011, they raised Rs. 63 crore through IPO and their shares officially listed on stock exchanges in September 2011.

Their current manufacturing facility at Baddi is 100% operational, with world class dedicated carbapenem facility in Vadodara Plant which commenced activity on 7 March 2017. Baddi facility was upgraded in June 2017 for 3 months, and production in injectable line resumed from September onwards. Finally, production commenced in August 2017 in the renovated building and was almost double than the previous line.

Revenue: ₹23.45Cr as on September 2025 (Q2 FY26)
Net Profit: ₹7.98Cr as on September 2025 (Q2 FY26)
Listing date: 05 Sep, 2011
OrganisationBrooks Laboratories Ltd
HeadquartersMumbai
IndustryPharmaceuticals
E-voting on sharesClick here to vote

FAQs

What is Brooks Laboratories share price today?

Brooks Laboratories share price today stands at ₹61.9 as on at the close of the market. Brooks Laboratories share today touched a day high of ₹65.69 and a low of ₹61.6.

What is the 52 week high and 52 week low range for Brooks Laboratories share?

Brooks Laboratories touched a 52 week high of ₹173.65 and a 52 week low of ₹61.6. Brooks Laboratories share price today i.e. is closed at ₹61.9, which is -64.35% down from its 52 week high and 0.49% up from its 52 week low.

What is Brooks Laboratories's market capitalisation today?

Brooks Laboratories market capitalisation is ₹189.70 Cr as on .

How to buy Brooks Laboratories shares?

To buy Brooks Laboratories shares, you need to follow these steps:

  • Open a Demat account and Trading account on INDmoney
  • Fund your Trading account
  • Search for BROOKS or Brooks Laboratories Ltd on the INDmoney app to check live prices of the stock
  • Click on Buy or SIP to place an order to invest in Brooks Laboratories shares. You can invest by selecting the number of shares or set up a fixed SIP to invest every month or week.

What is Brooks Laboratories trading volume today?

Brooks Laboratories trading volume is 57.86K as on . This means that 57.86K shares of Brooks Laboratories were bought and sold on the stock market during today's trading session.